Quality by design enabled formulation development of regorafenib monohydrate loaded PEGylated PLGA polymeric nanoparticles: Enhanced oral bioavailability and biopharmaceutical attributes
Objective(s): Using a quality-by-design methodology, the current research is aimed to prepare and enhance the PEGylated PLGA-loaded regorafenib monohydrate polymeric nanoparticles for enhancing oral bioavailability and biopharmaceutical attributes. The oral multi-kinase inhibitor inhibits VEGFR2-TIE...
Saved in:
| Main Authors: | Dhananjay Panigrahi, Suryakanta Swain, Pratap Sahu, Debashish Ghose, Bikash Ranjan Jena |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Mashhad University of Medical Sciences
2024-10-01
|
| Series: | Nanomedicine Journal |
| Subjects: | |
| Online Access: | https://nmj.mums.ac.ir/article_24729_285ef57c987090066db90e2add2fc123.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A Pharmacokinetic Study of the Interaction Between Regorafenib and Paracetamol in Male Rats
by: Agnieszka Karbownik, et al.
Published: (2024-10-01) -
Uso de regorafenibe em pacientes com câncer colorretal metastático previamente tratados com bevacizumabe ou aflibercepte: experiência clínica uni-institucional
by: Rodrigo Nogueira Fogace, et al.
Published: (2017-10-01) -
Synergistic effect of regorafenib with aminoglycosides in ferroptosis-mediated liver injury
by: Maha Raja Dahar, et al.
Published: (2025-07-01) -
The phosphatase CTDSPL2 promotes proliferation, invasion, metastasis and regorafenib resistance in osteosarcoma
by: Guannan Bai, et al.
Published: (2025-06-01) -
The efficacy of regorafenib monotherapy as the third-and later-line treatment for metastatic colorectal cancer: a retrospective study
by: An Tianqi, et al.
Published: (2022-08-01)